patient view
This page is a research summary built from public sources (FDA, NIH, clinical trial registries). It is not medical advice.Always talk to your doctor about treatment decisions. Drug information here may be incomplete or out of date — verify with your prescriber and the manufacturer's package insert.
drug · protein
sargramostim
Phase 3updated 2mo agoby Partner Therapeutics Inc🔗 ChEMBL
Phase 3community read0 votes
Protein drug with a maximum clinical stage of Approval (across all indications), with 4 approved and 42 investigational indications.
targets
Granulocyte-macrophage colony-stimulating factor receptor
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that